Elevated serum aminotransferase level as a predictor of intracerebral hemorrhage: Korea Medical Insurance Corporation study

Stroke

Volumn 36, Issue 8, 2005, Pages 1642-1647

  Kim, Hyeon Chang ^a   Kang, Dae Ryong ^a   Nam, Chung Mo ^a   Hur, Nam Wook ^a   Shim, Jee Seon ^a   Jee, Sun Ha ^b   Suh, Il ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

Alanine aminotransferase; Aspartate aminotransferase; Epidemiology; Intracerebral hemorrhage; Risk factors

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLUCOSE;

ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; BODY MASS; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DEATH; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEALTH INSURANCE; HOSPITAL ADMISSION; HUMAN; INCIDENCE; KOREA; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; SEX RATIO; SMOKING; STATISTICAL ANALYSIS; STROKE; SUBARACHNOID HEMORRHAGE;

ADULT; ALANINE TRANSAMINASE; ASPARTIC ACID; BLOOD PRESSURE; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; CEREBROVASCULAR ACCIDENT; FEMALE; FOLLOW-UP STUDIES; GLUCOSE; HUMANS; KOREA; MALE; MIDDLE AGED; OBESITY; PROPORTIONAL HAZARDS MODELS; RISK; RISK FACTORS; SUBARACHNOID HEMORRHAGE; TIME FACTORS; TRANSAMINASES;

EID: 23244466294     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000173404.37692.9b     Document Type: Article

References (30)

1. Salvaggio A, Periti M, Miano L, Tavanelli M, Marzorati D. Body mass index and liver enzyme activity in serum. Clin Chem. 1991;37:720-723.
2. Piton A, Poynard T, Imbert-Bismut F, Khalil L, Delattre J, Pelissier E, Sansonetti N, Opolon P. Factors associated with serum alanine transaminase activity in healthy subjects. Hepatology. 1998;27: 1213-1219.
3. Lee DH, Ha MH, Christiani DC. Body weight, alcohol consumption and liver enzyme activity: a 4-year follow-up study. Int J Epidemiol. 2001; 30:766-770.
4. Bruckert E, Giral P, Ratziu V, Poynard T, Chapman MJ, Opolon P, Turpin G. A constellation of cardiovascular risk factors is associated with hepatic enzyme elevation in hyperlipidemic patients. Metabolism. 2002; 51:1071-1076.
5. Bedogni G, Miglioli L, Battistini N, Masutti F, Tiribelli C, Bellentani S. Body mass index is a good predictor of an elevated alanine transaminase level in the general population: hints from the Dionysos study. Dig Liver Dis. 2003;35:648-652.
6. Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol. 2003;98:960-967.
7. Kim HC, Nam CM, Jee SH, Han KH, Oh DK, Suh I. Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study. BMJ. 2004;328:983-986.
8. Stranges S, Dorn JM, Muti P, Freudenheim JL, Farinaro E, Russell M, Nochajski TH, Trevisan M. Body fat distribution, relative weight, and liver enzyme levels: a population-based study. Hepatology. 2004;39: 754-763.
9. Boudouresques G, Hauw JJ, Meininger V, Escourolle R, Pertuiset B, Buge A, Lhermitte F, Castaigne P. Hepatic cirrhosis and intracranial hemorrhage: significance of the association in 53 pathological cases. Ann Neurol. 1980;8:204-205.
10. Niizuma H, Suzuki J, Yonemitsu T, Otsuki T. Spontaneous intracerebral hemorrhage and liver dysfunction. Stroke. 1988;19:852-856.
11. Fujii Y, Takeuchi S, Tanaka R, Koike T, Sasaki O, Minakawa T. Liver dysfunction in spontaneous intracerebral hemorrhage. Neurosurgery. 1994;35:592-596.
12. National Institutes of Health. The Sixth Report of the Joint National Committee on Prevention. Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda, Md: National Institutes of Health; NIH publication No. 98-4080, 1997.
13. Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, eds. Harrison's Principles of Internal Medicine. 15th ed. New York, NY: McGraw-Hill; 2001:A-2.
14. Perry IJ, Wannamethee SG, Shaper AG. Prospective study of serum γ-glutamyltransferase and risk of NIDDM. Diabetes Care. 1998;21: 732-737.
15. Nakanishi N, Nishina K, Li W, Sato M, Suzuki K, Tatara K. Serum γ-glutamyltransferase and development of impaired fasting glucose or type 2 diabetes in middle-aged Japanese men. J Intern Med. 2003;254: 287-295.
16. Lee DH, Jacobs DR Jr, Gross M, Kiefe CI, Roseman J, Lewis CE, Steffes M. γ-Glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem. 2003;49:1358-1366.
17. Reynolds K, Lewis B, Nolen JD, Kinney GL, Sathya B, He J. Alcohol consumption and risk of stroke: a meta-analysis. JAMA. 2003;289: 579-588.
18. Iso H, Baba S, Mannami T, Sasaki S, Okada K, Konishi M, Tsugane S; JPHC Study Group. Alcohol consumption and risk of stroke among middle-aged men: the JPHC Study Cohort I. Stroke. 2004;35:1124-1129.
19. Yano K, Reed DM, MacLean CH. Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program. Stroke. 1989;20:1460-1465.
20. Neaton JD, Blackburn H, Jacobs D, Kuller L, Lee DJ, Sherwin R, Shih J, Stamler J, Wentworth D, the Multiple Risk Factor Intervention Trial Research Group. Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Arch Intern Med. 1992;152:1490-1500.
21. Puddey IB. Low serum cholesterol and the risk of cerebral haemorrhage. Atherosclerosis. 1996;119:1-6.
22. Suh I, Jee SH, Kim HC, Nam CM, Kim IS, Appel LJ. Low serum cholesterol and haemorrhagic stroke in men: Korea Medical Insurance Corporation Study. Lancet. 2001;357:922-925.
23. Wannamethee G, Ebrahim S, Shaper AG. γ-Glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol. 1995;142:699-708.
24. Bots ML, Salonen JT, Elwood PC, Nikitin Y, Freire de Concalves A, Inzitari D, Sivenius J, Trichopoulou A, Tuomilehto J, Koudstaal PJ, Grobbee DE. γ-Glutamyltransferase and risk of stroke: the EURO-STROKE project. J Epidemiol Community Health. 2002;56(suppl 1):i25-i29.
25. Lee DH, Ha MH, Kim KY, Jin DG, Jacobs DR. γ-Glutamyltransferase: an effect modifier in the association between age and hypertension in a 4-year follow-up study. J Hum Hypertens. 2004;18:803-807.
26. Scott J. Pathophysiology and biochemistry of cardiovascular disease. Curr Opin Genet Dev. 2004;14:271-279.
27. Woo J, Lau E, Kay R. Elderly subjects aged 70 years and above have different risk factors for ischemic and hemorrhagic strokes compared to younger subjects. J Am Geriatr Soc. 1992;40:124-129.
28. Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913.
29. Ariesen MJ, Claus SP, Rinkel GJE, Algra A. Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke. 2003; 34:2060-2066.
30. Ministry of Health and Welfare. Pilot Test of National Cardiovascular Disease Surveillance System. Seoul, Korea: Ministry of Health and Welfare; 2000.